Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines Zejia YangPatrick J. FaustinoKevin J. Cullen ORIGINAL ARTICLE Pages: 255 - 262
Camptothecin analogues with enhanced antitumor activity at acidic pH David J. AdamsMark W. DewhirstMonroe E. Wall ORIGINAL ARTICLE Pages: 263 - 271
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer Nagio TakigawaYoshihiko SegawaMine Harada ORIGINAL ARTICLE Pages: 272 - 278
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia Federico PeaDomenico RussoMario Furlanut ORIGINAL ARTICLE Pages: 279 - 286
Selective modulation of P-glycoprotein's ATPase and anion efflux regulation activities with PKC α and PKC ɛ in Sf9 cells Haitham IdrissVirginia UrquidiSrisaila Basavappa ORIGINAL ARTICLE Pages: 287 - 292
Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents Ku LuChuan ShihBeverly A. Teicher ORIGINAL ARTICLE Pages: 293 - 304
In vitro evaluation of newly developed chalcone analogues in human cancer cells Rosa De VincenzoCristiano FerliniGiovanni Scambia ORIGINAL ARTICLE Pages: 305 - 312
Inhaled aerosolization of all-trans-retinoic acid for targeted pulmonary delivery Ari D. BrooksWilliam TongRaymond P. Warrell Jr ORIGINAL ARTICLE Pages: 313 - 318
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusion Jeffrey G. SupkoThomas J. LynchJoseph Paul Eder Jr ORIGINAL ARTICLE Pages: 319 - 328
Multiple factors other than p53 influence colon cancer sensitivity to paclitaxel Neeraj SharmaSatya RamachandranBennett W. Yu ORIGINAL ARTICLE Pages: 329 - 337
A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancer Ian N. OlverJennifer StephensonDoreen Schulze CLINICAL TRIAL REPORT Pages: 338 - 341
